Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumour DNA in B‐cell lymphomas: current state and future prospects

7 Feb 2021

Abstract excerpt

Circulating tumour DNA (ctDNA) is a highly versatile analyte and an emerging biomarker for detection of tumour-specific sequences in lymphoid malignancies. Since ctDNA is derived from tumour cells throughout the body, it overcomes fundamental limitations of tissue biopsies by capturing the complete molecular profile of tumours, including those from inaccessible anatomic locations. Assays for ctDNA are minimally...

Topics

Join the communities discussing this publication.

Cancer Genomics and Diagnostics
Lung Cancer Treatments and Mutations
Lymphoma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33550600
DOI: 10.1111/bjh.17251

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumour DNA in B‐cell lymphomas: current state and future prospectsPMID 33550600Read ↗

Circulating Tumor DNA in Lymphoma: Principles and Future DirectionsSemantic proximity Read ↗

Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational researchSemantic proximity Read ↗

Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas.Semantic proximity Read ↗

Clinical use of circulating tumor DNA analysis in patients with lymphomaSemantic proximity Read ↗

Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature ReviewSemantic proximity Read ↗

[Progression and application of circulating tumor DNA in lymphoma].Semantic proximity Read ↗

Circulating Tumor DNA in Lymphoma.Semantic proximity Read ↗

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.Semantic proximity Read ↗

Cell-free DNA in cancer: current insightsSemantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Circulating tumor DNA: current challenges for clinical utility.Semantic proximity Read ↗

The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.